Our innovation methodology. A four-step process
Innovation is the energy that drives us. Only through it can we offer the highest quality lenses. More than 15 years of researching and developing digital ophthalmic lenses have taken us to the next level. We have in-depth knowledge of all aspects of lens design.
Innovation is part of our DNA, of everything we do.
We offer disruptive and different solutions.
We are building the future of ophthalmic lenses.
Our method: we are open-minded and we observe and listen.
We analyze every comment we receive from wearers and the various players in the industry. We combine them with our latest technical developments. And we add our knowledge and experience. That’s how we develop new products
Think-tanks. Our research centers are just that. We exchange information with other R&D labs and universities. We carefully analyze the market. All this helps us transform new ideas into cutting-edge products.
Your ideas are essential for us to innovate. Share them with us. The synergy created between us generates highly innovative products that benefit both you and us.
We are curious. We’re always looking for new solutions and added value in our products. We go beyond lens design. Our latest developments: photochromic lenses and treatments.
Innovation is not just a spark of ingenuity. It needs to be present throughout the whole creative process. That’s why we also help you audit the complex manufacturing process. We resolve any issues quickly and efficiently. And we help you implement a quality control system.
We have developed our own clinical trial methods. Once conducted, we analyze the results and generate new lens designs and calculation methods. We believe this is the only way to improve the wearer’s visual experience.
Innovating means being able to offer different solutions that respond to market demands. The key is to listen carefully to what wearers and industry professionals are saying. That’s why we conduct around 20 clinical trials annually at our headquarters, with some 600 participants. Their feedback is crucial.
Annual clinical trials
A four-step process
Our innovation process is a cycle that includes a constant feedback loop.
We detect the potential
The first thing we do is to detect a gap or a need in the market. Through our clinical trials, we find out the real visual needs of wearers. Our partners and other industry professionals also inform us about their needs. And we generate our own ideas.
We transform an opportunity into a product or a technology
With the information gathered, we formulate a hypothesis and develop new technologies and tools. With these, we create a prototype to help improve lens designs or create new products.
We prove that it works
We need to validate or reject the new product. We do that by conducting wearer trials. All our clinical studies follow strict protocols under highly controlled conditions. And they’re designed and executed by an experienced team of scientists, engineers, and technical specialists. Our results are extremely reliable. When the wearer tests have been successful, we validate the product. Only then are we ready to offer it to you.
We make our findings known
We believe that part of the process involves sharing the technical knowledge we have acquired with the scientific community. That’s why we present our findings in scientific publications and at international optical conventions.
More about IOT Intelligence
Our innovation ecosystem
We enjoy innovating with our partners. Through our mutual exchange of information, we get great ideas for our products, and yours!
IOT Freeform Designer (LDS)
Its powerful algorithms make it possible to calculate lenses in seconds, adapting them to the individual data of each wearer.
IOT Intelligence has resulted in a collection of innovative products and technologies that allow our partners to manufacture the highest quality lenses.
By combining complex curvatures on both lens surfaces, this technology provides excellent vision correction. It is specially designed to increase reading zones and improve peripheral vision.
This methodology, patented by IOT, is a technological breakthrough in digital lenses. It provides a strict control of average power in the far distance vision zone and virtually eliminates peripheral spherical power error.
IOT Digital Ray-Path 2
Oblique aberrations are minimized more effectively than ever by incorporating the intelligent use of wearers’ accommodation into traditional calculations.
Metodologia Steady Plus
Steady Plus allows for more sophisticated control of the medium power distribution to improve performance for midrange and near vision. to achieve a perfectly symmetrical and smooth power distribution.